Evidence map›Paper›PMID 35058633›Full record

ArticleNature metabolism2022

Abnormal exocrine-endocrine cell cross-talk promotes β-cell dysfunction and loss in MODY8.

Sevim Kahraman, Ercument Dirice, Giorgio Basile, Danielle Diegisser, Jahedul Alam, Bente B Johansson, Manoj K Gupta, Jiang Hu, Ling Huang, Chew-Li Soh and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. ProtectiveiScience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Novel variation in theFrontiers in endocrinology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. mThe EMBO journal · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Sevim KahramanIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2880-6589
Ercument DiriceIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Giorgio BasileIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9900-4922
Danielle DiegisserIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Jahedul AlamGade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Bente B JohanssonCenter for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-8893-1915
Manoj K GuptaIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Jiang HuIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Ling HuangCancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8855-788X
Chew-Li SohMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Danwei HuangfuMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-1145-6199
Senthil K MuthuswamyCancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6564-9634
Helge Raeder *Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-9465-8580
Anders Molven *Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-1847-3079
Rohit N KulkarniIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA. Rohit.Kulkarni@joslin.harvard.edu.ORCID http://orcid.org/0000-0001-5029-6119
Joslin Diabetes Center · USBrigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USHaukeland University Hospital · NOMemorial Sloan Kettering Cancer Center · USUniversity of Bergen · NO

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement TherapyR01DK096239 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI HUANGFU, DANWEI · 2012 to 2021
$4.4M
Role of SerpinB1 in beta cell growthR01DK103215 · NIDDK · JOSLIN DIABETES CENTER · PI KULKARNI, ROHIT N. · 2014 to 2018
$2.6M
Special BD LSRFortessaS10OD021740 · OD · JOSLIN DIABETES CENTER · PI SERWOLD, THOMAS F · 2016 to 2016
$363k
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK096239NIDDK NIH HHS R01 DK103215NIDDK NIH HHS UC4 DK098085NIH HHS S10 OD021740
6 · The paper itself

Abstract

MODY8 (maturity-onset diabetes of the young, type 8) is a dominantly inherited monogenic form of diabetes associated with mutations in the carboxyl ester lipase (CEL) gene expressed by pancreatic acinar cells. MODY8 patients develop childhood-onset exocrine pancreas dysfunction followed by diabetes during adulthood. However, it is unclear how CEL mutations cause diabetes. In the present study, we report the transfer of CEL proteins from acinar cells to β-cells as a form of cross-talk between exocrine and endocrine cells. Human β-cells show a relatively higher propensity for internalizing the mutant versus the wild-type CEL protein. After internalization, the mutant protein forms stable intracellular aggregates leading to β-cell secretory dysfunction. Analysis of pancreas sections from a MODY8 patient reveals the presence of CEL protein in the few extant β-cells. The present study provides compelling evidence for the mechanism by which a mutant gene expressed specifically in acinar cells promotes dysfunction and loss of β-cells to cause diabetes.

Indexed as

Cell CommunicationAcinar CellsAnimalsDiabetes Mellitus, Type 2HumansImmunohistochemistryInsulin-Secreting CellsIslets of LangerhansIslets of Langerhans TransplantationLipaseMiceMutationPancreasPancreas, ExocrineProtein TransportSolubilityCEL protein, humanLipase

Identifiers

PMID35058633
PMCPMC12706769
OpenAlexW4205139704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.